| 标题 |
First-Line Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Extensive-Stage SCLC: A Long-Term Survival and Programmed Death-Ligand 1 Subgroup Analysis From the Randomized, Phase 3 RATIONALE-312 Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Thoracic Oncology 作者:Yun Fan; Yanqiu Zhao; Dingzhi Huang; Jun Zhao; Tai Qin; et al 出版日期:2026-03-07 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)